Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Codelivery of a cytotoxin and photosensitiser via a liposomal nanocarrier : A novel strategy for light-triggered cytosolic release

Yaghini, Elnaz ; Dondi, Ruggero ; Edler, Karen J. LU orcid ; Loizidou, Marilena ; MacRobert, Alexander J. and Eggleston, Ian M. (2018) In Nanoscale 10(43). p.20366-20376
Abstract

Endosomal entrapment is a key issue for the intracellular delivery of many nano-sized biotherapeutics to their cytosolic or nuclear targets. Photochemical internalisation (PCI) is a novel light-based solution that can be used to trigger the endosomal escape of a range of bioactive agents into the cytosol leading to improved efficacy in pre-clinical and clinical studies. PCI typically depends upon the endolysosomal colocalisation of the bioactive agent with a suitable photosensitiser that is administered separately. In this study we demonstrate that both these components may be combined for codelivery via a novel multifunctional liposomal nanocarrier, with a corresponding increase in the biological efficacy of the encapsulated agent. As... (More)

Endosomal entrapment is a key issue for the intracellular delivery of many nano-sized biotherapeutics to their cytosolic or nuclear targets. Photochemical internalisation (PCI) is a novel light-based solution that can be used to trigger the endosomal escape of a range of bioactive agents into the cytosol leading to improved efficacy in pre-clinical and clinical studies. PCI typically depends upon the endolysosomal colocalisation of the bioactive agent with a suitable photosensitiser that is administered separately. In this study we demonstrate that both these components may be combined for codelivery via a novel multifunctional liposomal nanocarrier, with a corresponding increase in the biological efficacy of the encapsulated agent. As proof of concept, we show here that the cytotoxicity of the 30 kDa protein toxin, saporin, in MC28 fibrosarcoma cells is significantly enhanced when delivered via a cell penetrating peptide (CPP)-modified liposome, with the CPP additionally functionalised with a photosensitiser that is targeted to endolysosomal membranes. This innovation opens the way for the efficient delivery of a range of biotherapeutics by the PCI approach, incorporating a clinically proven liposome delivery platform and using bioorthogonal ligation chemistries to append photosensitisers and peptides of choice.

(Less)
Please use this url to cite or link to this publication:
author
; ; ; ; and
publishing date
type
Contribution to journal
publication status
published
in
Nanoscale
volume
10
issue
43
pages
11 pages
publisher
Royal Society of Chemistry
external identifiers
  • pmid:30376028
  • scopus:85056299579
ISSN
2040-3364
DOI
10.1039/c8nr04048f
language
English
LU publication?
no
additional info
Publisher Copyright: © 2018 The Royal Society of Chemistry.
id
d276af6c-3317-40e0-9d4d-7e672006efce
date added to LUP
2023-01-18 09:09:13
date last changed
2024-03-06 11:22:05
@article{d276af6c-3317-40e0-9d4d-7e672006efce,
  abstract     = {{<p>Endosomal entrapment is a key issue for the intracellular delivery of many nano-sized biotherapeutics to their cytosolic or nuclear targets. Photochemical internalisation (PCI) is a novel light-based solution that can be used to trigger the endosomal escape of a range of bioactive agents into the cytosol leading to improved efficacy in pre-clinical and clinical studies. PCI typically depends upon the endolysosomal colocalisation of the bioactive agent with a suitable photosensitiser that is administered separately. In this study we demonstrate that both these components may be combined for codelivery via a novel multifunctional liposomal nanocarrier, with a corresponding increase in the biological efficacy of the encapsulated agent. As proof of concept, we show here that the cytotoxicity of the 30 kDa protein toxin, saporin, in MC28 fibrosarcoma cells is significantly enhanced when delivered via a cell penetrating peptide (CPP)-modified liposome, with the CPP additionally functionalised with a photosensitiser that is targeted to endolysosomal membranes. This innovation opens the way for the efficient delivery of a range of biotherapeutics by the PCI approach, incorporating a clinically proven liposome delivery platform and using bioorthogonal ligation chemistries to append photosensitisers and peptides of choice.</p>}},
  author       = {{Yaghini, Elnaz and Dondi, Ruggero and Edler, Karen J. and Loizidou, Marilena and MacRobert, Alexander J. and Eggleston, Ian M.}},
  issn         = {{2040-3364}},
  language     = {{eng}},
  month        = {{11}},
  number       = {{43}},
  pages        = {{20366--20376}},
  publisher    = {{Royal Society of Chemistry}},
  series       = {{Nanoscale}},
  title        = {{Codelivery of a cytotoxin and photosensitiser <i>via </i>a liposomal nanocarrier : A novel strategy for light-triggered cytosolic release}},
  url          = {{http://dx.doi.org/10.1039/c8nr04048f}},
  doi          = {{10.1039/c8nr04048f}},
  volume       = {{10}},
  year         = {{2018}},
}